Compare ABCL & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | BDC |
|---|---|---|
| Founded | 2012 | 1902 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 2020 | 1994 |
| Metric | ABCL | BDC |
|---|---|---|
| Price | $12.19 | $105.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $16.82 | ★ $151.20 |
| AVG Volume (30 Days) | ★ 4.3M | 317.9K |
| Earning Date | 11-09-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.19% |
| EPS Growth | 10.91 | ★ 23.13 |
| EPS | N/A | ★ 2.75 |
| Revenue | $75,128,000.00 | ★ $2,715,194,000.00 |
| Revenue This Year | N/A | $24.20 |
| Revenue Next Year | $7.12 | $17.18 |
| P/E Ratio | ★ N/A | $35.14 |
| Revenue Growth | ★ 160.56 | 10.33 |
| 52 Week Low | $2.75 | $96.06 |
| 52 Week High | $14.98 | $159.99 |
| Indicator | ABCL | BDC |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 46.42 |
| Support Level | $11.78 | $102.41 |
| Resistance Level | $12.88 | $115.40 |
| Average True Range (ATR) | 0.83 | 4.47 |
| MACD | 0.01 | 0.54 |
| Stochastic Oscillator | 40.11 | 78.84 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.